Generate a tailored SOP for Dr. Ben Kong. Improve your application with a focused, well-structured draft.
Ben Kong is a Senior Research Fellow in the School of Clinical Medicine at the University of New South Wales, specializing in oncology and cancer research. He holds a BSc (Hons) and MBBS from the University of Sydney, a Graduate Certificate in Drug Development from UNSW, and a PhD from the University of Sydney. His research primarily focuses on poor outcomes in cancers, particularly lung and head and neck cancers. As a Medical Oncologist at Prince Wales Hospital, he is involved in treating patients and has a pivotal role in designing and conducting investigator-initiated clinical trials through the NHMRC Clinical Trials Centre. Ben has extensive experience in cancer immunology, having been part of the Dendritic Cell Research Group at the ANZAC Research Institute, where he characterized circulating dendritic cells in glioblastoma patients. He aims to develop effective treatments for brain cancer and is currently leading clinical research on lung cancer with brain metastases. Additionally, he is a member of the UNSW Australian Centre for NanoMedicine and mentors at the UNSW Founders Health10x Biotech Accelerator Program.
University of New South Wales • Sydney, NSW, Australia
Conducts advanced research in oncology and oversees clinical trials.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.